Download PDF
Horm Metab Res 2014; 46(12): 841-844
DOI: 10.1055/s-0034-1387798
Review
© Georg Thieme Verlag KG Stuttgart · New York

Role of Gsα in Central Regulation of Energy and Glucose Metabolism

L. S. Weinstein
1   Signal Transduction Section, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, USA
› Author Affiliations
Further Information

Publication History

received 12 May 2014

accepted 06 August 2014

Publication Date:
18 September 2014 (online)

Also available at
    Permissions and Reprints

Abstract

GNAS is a complex imprinted locus with multiple oppositely imprinted gene products, including the G protein α-subunit Gsα that is expressed primarily from the maternal allele in some tissues and the Gsα isoform XLαs that is expressed only from the paternal allele. Maternal Gsα mutations in mice and in patients with Albright hereditary osteodystrophy lead to obesity, insulin resistance, and hyperlipidemia. Studies in mice show that these effects are primarily due to Gsα imprinting in the central nervous system and that Gsα deficiency in one or more regions of the central nervous system lead to reduced sympathetic nervous system and energy expenditure without affecting food intake. Loss of Gsα in the central nervous system appears to lead to these effects primarily through impairment of melanocortin signaling. Loss of XLαs in mice leads to opposite effects on energy and glucose metabolism.

Key words

genomic imprinting - obesity - pseudohypoparathyroidism - Albright hereditary osteodystrophy
 

  • References

  • 1 Weinstein LS, Xie T, Zhang QH, Chen M. Studies of the regulation and function of the Gsα gene Gnas using gene targeting technology. Pharmacol Ther 2007; 115: 271-291
    CrossrefPubMedGoogle Scholar
  • 2 Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 1997; 66: 807-822
    CrossrefPubMedGoogle Scholar
  • 3 Davies SJ, Hughes HE. Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993; 30: 101-103
    CrossrefPubMedGoogle Scholar
  • 4 Weinstein LS, Chen M, Xie T, Liu J. Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol Sci 2006; 27: 260-266
    CrossrefPubMedGoogle Scholar
  • 5 Yu S, Yu D, Lee E, Eckhaus ME, Lee R, Corria Z, Accili D, Westphal H, Weinstein LS. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein α-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the Gsα gene. Proc Natl Acad Sci USA 1998; 95: 8715-8720
    Google Scholar
  • 6 Liu J, Erlichman B, Weinstein LS. The stimulatory G protein α-subunit Gsα is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 2003; 88: 4336-4341
    CrossrefPubMedGoogle Scholar
  • 7 Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A. The Gsα gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002; 87: 4736-4740
    Google Scholar
  • 8 Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT. Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001; 107: R31-R36
    Google Scholar
  • 9 Germain-Lee EL, Ding C, Deng Z, Crane JL, Saji M, Ringel MD, Levine MA. Paternal imprinting of Gαs in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002; 296: 67-72
    Google Scholar
  • 10 Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism implicate paternal imprinting of Gαs in the development of human obesity. J Clin Endocrinol Metab 2007; 92: 1073-1079
    CrossrefPubMedGoogle Scholar
  • 11 Carel JC, Le Stunff C, Condamine L, Mallet E, Chaussain JL, Adnot P, Garabedian M, Bougneres P. Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency. J Clin Endocrinol Metab 1999; 84: 4127-4131
    CrossrefPubMedGoogle Scholar
  • 12 Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, Wand G, Huso DL, Saji M, Ringel MD, Levine MA. A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology 2005; 146: 4697-4709
    CrossrefPubMedGoogle Scholar
  • 13 Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT, Nackers LM, Lorenzo J, Shen L, Weinstein LS. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci USA 2005; 102: 7386-7391
    CrossrefPubMedGoogle Scholar
  • 14 Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A. Biallelic expression of the Gsα gene in human bone and adipose tissue. J Clin Endocrinol Metab 2004; 89: 6316-6319
    CrossrefPubMedGoogle Scholar
  • 15 Shoemaker AH, Lomenick JP, Saville BR, Wang W, Buchowski MS, Cone RD. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond) 2013; 37: 1147-1153
    CrossrefPubMedGoogle Scholar
  • 16 Muniyappa R, Warren MA, Zhao X, Aney SC, Courville AB, Chen KY, Brychta RJ, Germain-Lee EL, Weinstein LS, Skarulis MC. Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 2013; 98: E1796-E1801
    CrossrefPubMedGoogle Scholar
  • 17 Dekelbab BH, Aughton DJ, Levine MA. Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr Pract 2009; 15: 249-253
    CrossrefPubMedGoogle Scholar
  • 18 Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003; 88: 4059-4069
    CrossrefPubMedGoogle Scholar
  • 19 Nwosu BU, Lee MM. Pseudohypoparathyroidism type 1a and insulin resistance in a child. Nat Rev Endocrinol 2009; 5: 345-350
    CrossrefPubMedGoogle Scholar
  • 20 Kelly ML, Moir L, Jones L, Whitehill E, Anstee QM, Goldin RD, Hough A, Cheeseman M, Jansson JO, Peters J, Cox RD. A missense mutation in the non-neural G-protein α-subunit isoforms modulates susceptibility to obesity. Int J Obes (Lond) 2009; 33: 507-518
    CrossrefPubMedGoogle Scholar
  • 21 Xie T, Chen M, Gavrilova O, Lai EW, Liu J, Weinstein LS. Severe obesity and insulin resistance due to deletion of the maternal Gsα allele is reversed by paternal deletion of the Gsα imprint control region. Endocrinology 2008; 149: 2443-2450
    CrossrefPubMedGoogle Scholar
  • 22 Yu S, Gavrilova O, Chen H, Lee R, Liu J, Pacak K, Parlow AF, Quon MJ, Reitman ML, Weinstein LS. Paternal versus maternal transmission of a stimulatory G protein α subunit knockout produces opposite effects on energy metabolism. J Clin Invest 2000; 105: 615-623
    CrossrefPubMedGoogle Scholar
  • 23 Yu S, Castle A, Chen M, Lee R, Takeda K, Weinstein LS. Increased insulin sensitivity in Gsα knockout mice. J Biol Chem 2001; 276: 19994-19998
    CrossrefPubMedGoogle Scholar
  • 24 Chen M, Haluzik M, Wolf NJ, Lorenzo J, Dietz KR, Reitman ML, Weinstein LS. Increased insulin sensitivity in paternal Gnas knockout mice Is associated with increased lipid clearance. Endocrinology 2004; 145: 4094-4102
    CrossrefPubMedGoogle Scholar
  • 25 Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G. The imprinted signaling protein XLαs is required for postnatal adaptation to feeding. Nat Genet 2004; 36: 818-826
    CrossrefPubMedGoogle Scholar
  • 26 Xie T, Plagge A, Gavrilova O, Pack S, Jou W, Lai EW, Frontera M, Kelsey G, Weinstein LS. The alternative stimulatory G protein α-subunit XLαs is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice. J Biol Chem 2006; 281: 18989-18999
    CrossrefPubMedGoogle Scholar
  • 27 Genevieve D, Sanlaville D, Faivre L, Kottler ML, Jambou M, Gosset P, Boustani-Samara D, Pinto G, Ozilou C, Abeguile G, Munnich A, Romana S, Raoul O, Cormier-Daire V, Vekemans M. Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties. Eur J Hum Genet 2005; 13: 1033-1039
    CrossrefPubMedGoogle Scholar
  • 28 Xie T, Chen M, Zhang QH, Ma Z, Weinstein LS. β cell-specific deficiency of the stimulatory G protein α-subunit Gsα leads to reduced β cell mass and insulin-deficient diabetes. Proc Natl Acad Sci USA 2007; 104: 19601-19606
    CrossrefPubMedGoogle Scholar
  • 29 Chen M, Chen H, Nguyen A, Gupta D, Wang J, Lai EW, Pacak K, Gavrilova O, Quon MJ, Weinstein LS. Gsα deficiency in adipose tissue leads to a lean phenotype with divergent effects on cold tolerance and diet-induced thermogenesis. Cell Metab 2010; 11: 320-330
    CrossrefPubMedGoogle Scholar
  • 30 Chen M, Gavrilova O, Zhao W-Q, Nguyen A, Lorenzo J, Shen L, Nackers L, Pack S, Jou W, Weinstein LS. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gsα deficiency. J Clin Invest 2005; 115: 3217-3227
    CrossrefPubMedGoogle Scholar
  • 31 Chen M, Feng HZ, Gupta D, Kelleher J, Dickerson KE, Wang J, Hunt D, Jou W, Gavrilova O, Jin JP, Weinstein LS. Gsα deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency. Am J Physiol Cell Physiol 2009; 296: C930-C940
    CrossrefPubMedGoogle Scholar
  • 32 Xie T, Chen M, Weinstein LS. Pancreas-specific Gsα deficiency has divergent effects on pancreatic α- and β-cell proliferation. J Endocrinol 2010; 206: 261-269
    CrossrefPubMedGoogle Scholar
  • 33 Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, Gupta D, Lai EW, Pacak K, Gavrilova O, Weinstein LS. Central nervous system imprinting of the G protein Gsα and its role in metabolic regulation. Cell Metab 2009; 9: 548-555
    CrossrefPubMedGoogle Scholar
  • 34 Chen M, Berger A, Kablan A, Zhang J, Gavrilova O, Weinstein LS. Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations. Endocrinology 2012; 153: 4256-4265
    CrossrefPubMedGoogle Scholar
  • 35 Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castanada TR, Neschen S, Hofmann SM, Howles PN, Morgan DA, Benoit SC, Szanto I, Schrott B, Schurmann A, Joost H-G, Hammond C, Hui DY, Woods SC, Rahmouni K, Butler AA, Farooqi IS, O’Rahilly S, Rohner-Jeanrenaud F, Tschop MH. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007; 117: 3475-3488
    CrossrefPubMedGoogle Scholar
  • 36 Butler AA, Cone RD. The melanocortin receptors: lessons from knockout models. Neuropeptides 2002; 36: 77-84
    CrossrefPubMedGoogle Scholar
  • 37 Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007; 148: 5339-5347
    CrossrefPubMedGoogle Scholar
  • 38 Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141
    CrossrefPubMedGoogle Scholar
  • 39 Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095
    CrossrefPubMedGoogle Scholar
  • 40 Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 1999; 21: 119-122
    CrossrefPubMedGoogle Scholar
  • 41 Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, Marsh DJ, Forrest MJ, Gopal-Truter S, Fisher J, Camacho RE, Strack AM, Mellin TN, MacIntyre DE, Chen HY, Van der Ploeg LH. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 2000; 9: 145-154
    CrossrefPubMedGoogle Scholar
  • 42 Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000; 141: 3072-3079
    CrossrefPubMedGoogle Scholar
  • 43 Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest 2001; 108: 1079-1085
    CrossrefPubMedGoogle Scholar
  • 44 Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 2001; 4: 605-611
    CrossrefPubMedGoogle Scholar
  • 45 Voss-Andreae A, Murphy JG, Ellacott KLJ, Stuart RC, Nillni EA, Cone RD, Fan W. Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology 2007; 148: 1550-1560
    CrossrefPubMedGoogle Scholar
  • 46 Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O’Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52
    CrossrefPubMedGoogle Scholar
  • 47 Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 2005; 46: 326-332
    CrossrefPubMedGoogle Scholar